Why Is Polar Capital Global Healthcare Trust plc (LSE:PCGH) Up on 12 Nov 2026?

Polar Capital Global Healthcare Trust plc shares rose 0.74% to around 477.0p on 12 Nov 2026, a gain of 3.50p, based on market data.

Polar Capital Global Healthcare Trust plc is a London-listed Investment trust that aims to deliver capital growth by investing in a global portfolio of healthcare companies, and its share price can move with healthcare markets and with trust-specific factors.

As an investment trust, it publishes regular portfolio updates and periodic reports, so moves in its shares often reflect the performance of the underlying holdings and sentiment toward healthcare shares worldwide.

Key Highlights

Polar Capital Global Healthcare Trust is an investment trust launched in June 2010 that invests mainly in listed healthcare companies worldwide. Its portfolio spans pharmaceuticals, medical devices, biotechnology and healthcare services, and it typically holds between 25 and 60 stocks. The trust is actively managed, has no fixed life, and offers shareholders a tender opportunity every five years.

About Polar Capital Global Healthcare Trust plc

Polar Capital Global Healthcare Trust plc is a London-listed investment trust managed by Polar Capital. Its objective is capital growth from a diversified portfolio of healthcare stocks across regions, sub-sectors and company sizes. LSE:PCGH offers a way to access global healthcare companies through a single listed holding, with the portfolio chosen by an experienced specialist healthcare team.

Key Reasons Behind the 12 Nov 2026 Move

The 0.74% rise on 12 Nov 2026 may reflect improved sentiment toward healthcare shares, particularly in the United States where much of the portfolio is invested. Trust share prices can also move as the gap between the price and the value of underlying Assets changes. No specific announcement is verified for the day, so these explanations are general possibilities rather than confirmed causes.

How the Portfolio Is Built

The trust invests mainly in listed healthcare companies in pharmaceuticals, medical services, medical devices and biotechnology. Its managers describe the approach as high conviction and actively managed, with holdings spread by geography, sub-sector and company size. The portfolio is weighted most heavily to the United States, with smaller positions in the UK, Switzerland, Germany, Israel and Canada. Holdings and weightings differ from the benchmark index.

Trust Structure and Shareholder Features

As an investment trust, it has a fixed number of shares that trade on the exchange, so the share price may differ from the value of the underlying portfolio. The trust has no fixed life but offers tender opportunities every five years, with the next due by 31 March 2031. It pays dividends twice a year and may use modest gearing, which can magnify both gains and falls in the portfolio.

Key Growth Catalysts

Long-term Demand for healthcare, driven by ageing populations and medical innovation, may support the sector. Advances in areas such as biotechnology and medical devices could create opportunities for the portfolio. Active stock selection allows managers to adjust exposure as conditions change. A narrower discount between share price and portfolio value could support the trust's shares. Diversification across regions and sub-sectors may help balance exposure.

Key Considerations

Healthcare shares can be influenced by regulation, drug pricing debates and clinical trial outcomes. The trust's large United States weighting means currency movements and American policy developments may affect sterling returns. Gearing can increase volatility. The share price can trade at a discount or premium to the value of the underlying assets. Active management decisions may differ from the broader healthcare index.

Share Price Context

Based on market data, LSE:PCGH traded at around 477.0p on 12 Nov 2026, up 3.50p. Investment trusts report portfolio values regularly, so share price moves are best read alongside the latest net asset value and holdings information.

What to Watch Next

Investors may follow the trust's regular portfolio factsheets, its reported net asset value, the discount or premium at which the shares trade, and its Dividend announcements. Developments in healthcare regulation, drug pricing and innovation in the largest holdings are also relevant. The next tender opportunity date of 31 March 2031 forms part of the long-term structure.

Conclusion

Polar Capital Global Healthcare Trust plc shares rose 0.74% to around 477.0p on 12 Nov 2026, based on market data. Polar Capital Global Healthcare Trust offers diversified, actively managed access to global healthcare shares through a listed trust structure. LSE:PCGH is best followed through its net asset value, discount and the performance of its healthcare holdings.